EVH sentiment intelligence

Evolent To Release Second Quarter 2026 Financial Results on Thursday, August 6, 2026

Evolent Health, Inc. announced it will release its second quarter 2026 financial results on Thursday, August 6, 2026, before market open. A conference call will follow at 8 a.m. ET, accessible via Evolent's investor relations website, and an audio playback will be available for 9

Tone

Neutral 50/100

Event

Earnings

Published

09 Jul 2026 02:40

Source

Sahm

Evolent set to report Q2 2026 results before Aug. 6 call

Tone

Neutral 50/100

Event

Earnings

Published

08 Jul 2026 20:30

Source

Stock Titan

Evolent Health (EVH) president receives 302,585 RSUs in equity grant

Evolent Health, Inc. president Daniel McCarthy was granted 302,585 restricted stock units (RSUs) as part of an equity compensation package approved by the Compensation Committee. These RSUs will vest in three tranches on July 1, 2027, 2028, and 2029. In connection with this grant

Tone

Neutral 50/100

Event

Market update

Published

07 Jul 2026 14:39

Source

Stock Titan

Evolent Health (EVH) CEO gets 446,102 RSUs and has shares withheld for taxes

Evolent Health, Inc.'s CEO, Seth Blackley, was granted 446,102 restricted stock units (RSUs) with a vesting schedule extending to 2029. To cover tax obligations upon the vesting of these RSUs, 10,297 shares of Class A Common Stock, valued at $5.74 per share, were withheld. Follow

Tone

Neutral 50/100

Event

Market update

Published

06 Jul 2026 20:41

Source

Stock Titan

Evolent Health (EVH) General Counsel receives RSU grant with tax-withholding entry

Evolent Health's General Counsel, Jonathan Weinberg, received a grant of 43,055 restricted stock units (RSUs) on July 1, 2026, as part of his annual equity compensation. Concurrently, 2,650 shares were withheld to cover tax obligations upon the vesting of previously granted RSUs,

Tone

Neutral 50/100

Event

Market update

Published

06 Jul 2026 20:41

Source

Stock Titan

Evolent Health (EVH) grants 28,790 RSUs to Chief Accounting Officer

Evolent Health, Inc. (EVH) has granted 28,790 restricted stock units (RSUs) to its Chief Accounting Officer, Shams Aammaad, under the company's 2015 Omnibus Incentive Compensation Plan. These RSUs will vest in tranches: 34% on July 1, 2027, and 33% on both July 1, 2028, and July

Tone

Neutral 50/100

Event

Market update

Published

06 Jul 2026 19:41

Source

Stock Titan

Truist Downgrades Evolent Health to Hold From Buy, Keeps $7 Price Target, Cites Recent Share Price Strength, Medicaid Headwind

Tone

Neutral 50/100

Event

Analyst action

Published

30 Jun 2026 10:40

Source

MT Newswires

Strength Seen in Evolent Health (EVH): Can Its 9.5% Jump Turn into More Strength?

Tone

Neutral 50/100

Event

Market update

Published

29 Jun 2026 07:00

Source

Market source

Enterprise value to EBIT forward of Evolent Health Inc Class A – FWB:9EH

This page provides financial data for Evolent Health Inc Class A (FWB:9EH) on the Frankfurt Stock Exchange, specifically focusing on its enterprise value to EBIT forward. It indicates that the market is currently closed with no trades recorded. The data is presented within the Tr

Tone

Neutral 50/100

Event

Market update

Published

27 Jun 2026 11:10

Source

TradingView

Price to sales forward of Evolent Health Inc Class A – FWB:9EH

This article provides the "Price to sales forward" metric for Evolent Health Inc Class A (FWB:9EH) on the Frankfurt Stock Exchange. It appears to be a financial data point from TradingView, indicating a specific valuation ratio for the company over a given period, along with its

Tone

Neutral 50/100

Event

Market update

Published

27 Jun 2026 10:11

Source

TradingView

Evolent Health Inc Class A Actuals & Estimates (NYSE:EVH)

This article provides an overview of Evolent Health, Inc. (EVH) stock, including current market data, analyst forecasts, and detailed financial information. It covers the stock's price performance, market capitalization, earnings, revenue, and EBITDA, along with frequently asked

Tone

Neutral 50/100

Event

Earnings

Published

26 Jun 2026 03:10

Source

TradingView

Analysts Offer Insights on Healthcare Companies: Amneal Pharmaceuticals (AMRX), Evolent Health (EVH) and Celldex (CLDX)

This article highlights bullish sentiments from financial analysts on three healthcare companies: Amneal Pharmaceuticals (AMRX), Evolent Health (EVH), and Celldex (CLDX). UBS reiterated a Buy rating for Amneal Pharmaceuticals, while Truist Financial maintained a Buy rating for Ev

Tone

Neutral 50/100

Event

Analyst action

Published

14 Jun 2026 06:40

Source

The Globe and Mail

Q1 Earnings Outperformers: Evolent Health (NYSE:EVH) And The Rest Of The Healthcare Technology for Providers Stocks

Tone

Neutral 50/100

Event

Earnings

Published

12 Jun 2026 07:00

Source

Market source

Evolent Health (EVH) director Russell Glass receives 41,096 restricted stock units

Evolent Health, Inc. director Russell Monroe Glass was granted 41,096 restricted stock units (RSUs) of Class A Common Stock at $0.00 per share under the company’s 2015 Omnibus Incentive Compensation Plan. These RSUs are set to vest on the earlier of June 4, 2027, or the company's

Tone

Neutral 50/100

Event

Market update

Published

11 Jun 2026 18:09

Source

Stock Titan

Director at Evolent Health (EVH) receives 41,096-share RSU grant

Evolent Health director Brendan B. Springstubb was granted 41,096 restricted stock units (RSUs) of Class A Common Stock, valued at $0.00 per share, under the company's 2015 Omnibus Incentive Compensation Plan. Following this grant, his direct holdings total 99,917 shares. These R

Tone

Neutral 50/100

Event

Market update

Published

09 Jun 2026 11:10

Source

Stock Titan

Evolent Health (EVH) director receives 41,096 restricted stock units grant

Evolent Health, Inc. director Peter J. Grua was granted 41,096 restricted stock units (RSUs) of Class A Common Stock at $0.00 per share, as reported in a Form 4 filing. These RSUs are compensation-related and will vest on the earlier of June 4, 2027, or the company's 2027 annual

Tone

Neutral 50/100

Event

Market update

Published

09 Jun 2026 03:08

Source

Stock Titan

Evolent Health (EVH) director Kim Keck granted 41,096 restricted stock units

Evolent Health director Kim Keck was granted 41,096 restricted stock units (RSUs) under the company's 2015 Omnibus Incentive Compensation Plan, increasing her direct ownership to 102,597 shares. These RSUs will vest on the earlier of June 4, 2027, or the company’s 2027 annual mee

Tone

Neutral 50/100

Event

Market update

Published

09 Jun 2026 02:09

Source

Stock Titan

Equity grant lifts Evolent (NYSE: EVH) director Barbarosh holdings

Evolent Health director Craig A. Barbarosh was granted 41,096 restricted stock units (RSUs) as part of the company's 2015 Omnibus Incentive Compensation Plan, at no cash cost. These RSUs are set to vest by June 4, 2027, or the company's 2027 annual meeting, contingent on his cont

Tone

Neutral 50/100

Event

Balance sheet

Published

09 Jun 2026 00:09

Source

Stock Titan

Evolent Health (EVH) director receives 41,096 restricted stock units award

Jill D. Smith, a director at Evolent Health (EVH), was granted 41,096 restricted stock units (RSUs) as equity compensation, increasing her total direct holdings to 64,233 shares. These RSUs, part of the 2015 Omnibus Incentive Compensation Plan, will vest on the earlier of June 4,

Tone

Neutral 50/100

Event

Market update

Published

08 Jun 2026 20:09

Source

Stock Titan

[Form 4] Evolent Health, Inc. Insider Trading Activity

Evolent Health, Inc. director Shawn M. Guertin reported receiving an equity award of 41,096 restricted stock units of Class A Common Stock. These units were granted at no cash cost under the company's 2015 Omnibus Incentive Compensation Plan and vest on the earlier of June 4, 202

Tone

Neutral 50/100

Event

Balance sheet

Published

08 Jun 2026 20:09

Source

Stock Titan

Evolent Health (EVH) director receives 41,096 restricted stock units in equity grant

Richard M. Jelinek, a director at Evolent Health (EVH), received an equity grant of 41,096 restricted stock units (RSUs) with no purchase price. These RSUs will vest on the earlier of June 4, 2027, or the company's 2027 annual meeting, provided Jelinek continues his service. Foll

Tone

Neutral 50/100

Event

Market update

Published

08 Jun 2026 20:09

Source

Stock Titan

Evolent Health : EVH

Evolent Health Inc. (EVH) specializes in healthcare management, offering services in oncology, cardiology, and musculoskeletal care, backed by its Identifi technology. The company, founded in 2011 and based in Arlington, Virginia, supports health plan administration and provides

Tone

Neutral 50/100

Event

Market update

Published

20 May 2026 08:10

Source

24/7 Wall St.